期刊文献+

重组人脑利尿钠肽辅助治疗慢性充血性心力衰竭273例疗效观察 被引量:3

下载PDF
导出
摘要 目的观察重组人脑利钠肽(rh-BNP)治疗慢性充血性心力衰竭的临床疗效。方法将542例慢性充血性心力衰竭患者随机分为观察组273例和对照组269例,两组均采用常规治疗,观察组在此基础上加用rh-BNP。观察两组临床疗效,治疗前后左心室射血分数(LVEF)、6min步行距离,不良反应。结果观察组及对照组总有效率分别为91.3%、65.5%,P<0.05;观察组治疗前后LVEF分别为(31.4±3.9)%、(49±7.1)%,对照组分别为(32.8±4.1)%、(40.4±5.8)%,观察组治疗后高于治疗前及对照组,P<0.05;观察组治疗前后6min步行距离分别为(311±65)、(460±120)m,对照组分别为(320±70)、(370±60)m,观察组治疗后高于治疗前及对照组,P均<0.05。两组均无明显不良反应。结论rh-BNP治疗慢性充血性心力衰竭疗效确切,安全有效。
机构地区 无锡市人民医院
出处 《山东医药》 CAS 北大核心 2009年第51期69-70,共2页 Shandong Medical Journal
  • 相关文献

参考文献6

二级参考文献41

  • 1苏少慧,杨晶,王丽娜.脾梗死8例临床分析[J].临床荟萃,2002,17(24):1441-1442. 被引量:11
  • 2Van Cheng BS, Kazanegra R, Garcia A,et al. A rapid bedside test for B-type natriuretic peptide predicts treatment outcomes in patients admitted with decompensated heart failure[J]. J Am Coll Cardiol, 2001,37:386-391.
  • 3Grantham JA, Burnett JC. BNP, Increasing importance in the pathophysiology and diagnosis of congestive heart failure[J]. Circulation, 1997,96:388-390.
  • 4Mann DL. Mechanisms and models of heart failure : A combinatorial approach[J]. Circulation, 1999,100 : 999-1008.
  • 5Kazanegra R, Van Cheng BS, Garcia A,et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure:Apilot study[J]. J Cardiac Fail, 2001, 7:21-29.
  • 6Maeda K, Tsutamoto T, Wada A,et al. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure[J]. J Am Coil Cardiol, 2000,36:1587-1593.
  • 7Richards AM, Doughty R, Nicholls MG,et al. for the Australia-New Zealand Heart Failure Group: Neurohumoral predictors of benefit from earvedilol in isehemie left ventricular dysfunction[J]. Circulation, 1999,99: 786-797.
  • 8Troughton RW, Frampton CM, Yandle TG ,et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide concentrations[J]. Lancet, 2000, 355 : 1125-1130.
  • 9Maisel. B-type natriuretic peptide in the diagnosis and management of congestive heart failure [J]. Heart Failure. 2001,19:557-571.
  • 10Vinson JM, Rich MW, Sperry JC,et al. Early readmission of elderly patients with heart failure[J]. J Am Geriatr Soc,1990, 38:1290-1295,.

共引文献13

同被引文献41

  • 1王如兴,李肖蓉,邵力正,羊镇宇,肖春晖,王强,杨光敏.B型利钠肽对心源性呼吸困难鉴别诊断界值的研究[J].临床荟萃,2004,19(22):1277-1279. 被引量:7
  • 2Martin R,Gustavo F.BNP and Congrestive Heart Failure.Prog Cardiovascu Dis 2002,44(4):293-321.
  • 3Oliver P,Fox J,Kin R,et al.Hypertension.cardiac hypertrophy and sudden death in mice lacking natriuretic peptide receptor A.Proc Natl Acad Sci USA,1997,94:14730-14735.
  • 4Tamura N,Ogawa Y,Chusho H,et al.Cardiac fibrosis in mice lacking brain natriuretic peptide.Proc Natl Acad Sci USA,2000,97:4239-4244.
  • 5Elmers L,Knowles J.Ventricular expression of atrial and brain natriuretic peptide in NPR-1 deficientmice with cardiac hypertrophy and fibrosis.Am J Physiol,2002,283:707-714.
  • 6Vicky AC,Leigh J.M inireview,Natriuretic peptides during development of the fetal heart and circulation.Endocrinology,2003,144(6):2191-2194.
  • 7Surakit Nathisuwan,Robert L,Talbert A.Review of vasopeptidase inhibitors a new modality in the treament of hypertension and chronic heart failure.Pharmacotherapy,2002,22(1):27-42.
  • 8Miriam TR,Richard AM.Cardiac natriuretic peptides for cardiac health.Clinical Science,2005,108:23-36.
  • 9Osman R,Alat I,Coskun S,et al.The role of brain natriuretic peptide in the prediction of cardiac performace in coronary artery bypass grafting.Tex Heart Inst J,2003,30:298-304.
  • 10James A,Lemos MD,David A.Morrow MD.Brain natriuretic peptide measurement in actue coronary syndrome:Ready for clinical application.Circulation,2002,106:2868-2870.

引证文献3

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部